These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 7424945)

  • 21. Hemodynamic effects of orally administered isosorbide dinitrate in patients with congestive heart failure.
    Franciosa JA; Mikulic E; Cohn JN; Jose E; Fabie A
    Circulation; 1974 Nov; 50(5):1020-4. PubMed ID: 4609633
    [No Abstract]   [Full Text] [Related]  

  • 22. Nitrate therapy for congestive heart failure.
    Franciosa JA; Nordstrom LA; Cohn JN
    JAMA; 1978 Aug; 240(5):443-6. PubMed ID: 351232
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Haemodynamic advantages of isosorbide dinitrate over frusemide in acute heart-failure following myocardial infarction.
    Nelson GI; Silke B; Ahuja RC; Hussain M; Taylor SH
    Lancet; 1983 Apr; 1(8327):730-3. PubMed ID: 6132082
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antianginal effect of isosorbide dinitrate spray in patients with exercise-induced stable angina.
    Aärynen M; Soininen K
    J Int Med Res; 1986; 14(6):303-5. PubMed ID: 3803701
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nitrates in heart failure. Pathophysiological mechanisms and therapeutic applications.
    Timmis AD; Richardson PJ
    Scand J Clin Lab Invest Suppl; 1984; 173():59-64. PubMed ID: 6442003
    [No Abstract]   [Full Text] [Related]  

  • 26. A comparison between the effects of diltiazem and isosorbide dinitrate on digoxin pharmacodynamics and kinetics in the treatment of patients with chronic ischemic heart failure.
    Mahgoub AA; El-Medany AH; Abdulatif AS
    Saudi Med J; 2002 Jun; 23(6):725-31. PubMed ID: 12070557
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Haemodynamic effects of oral salbutamol alone and in combination with sublingual isosorbide dinitrate in patients with severe congestive cardiac failure.
    Stephens JD; Banim SO; Spurrell RA
    Br Heart J; 1980 Feb; 43(2):220-5. PubMed ID: 7362716
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Management of acute heart failure following myocardial infarction: hemodynamic advantages of isosorbide dinitrate over frusemide.
    Nelson GI; Silke B; Ahuja RC; Hussain M; Taylor SH
    Z Kardiol; 1983; 72 Suppl 3():141-6. PubMed ID: 6666215
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of intravenous isosorbide dinitrate versus nitroglycerin on elevated pulmonary arterial wedge pressure during acute myocardial infarction.
    Cintron GB; Glasser SP; Weston BA; Linares E; Conti CR
    Am J Cardiol; 1988 Jan; 61(1):21-5. PubMed ID: 3122548
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A prospective, randomized, double-blind, crossover study to compare the efficacy and safety of chronic nifedipine therapy with that of isosorbide dinitrate and their combination in the treatment of chronic congestive heart failure.
    Elkayam U; Amin J; Mehra A; Vasquez J; Weber L; Rahimtoola SH
    Circulation; 1990 Dec; 82(6):1954-61. PubMed ID: 2242521
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sustained effect of orally administered isosorbide dinitrate on exercise performance of patients with angina pectoris.
    Markis JE; Gorlin R; Mills RM; Williams RA; Schweitzer P; Ransil BJ
    Am J Cardiol; 1979 Feb; 43(2):265-71. PubMed ID: 367136
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative haemodynamic and peripheral vasodilator effects of oral and chewable isosorbide dinitrate in patients with refractory congestive cardiac failure.
    Figueras J; Taylor WR; Ogawa T; Forrester JS; Singh BN; Swan HJ
    Br Heart J; 1979 Mar; 41(3):317-24. PubMed ID: 371647
    [No Abstract]   [Full Text] [Related]  

  • 33. Effect of swallowed isosorbide dinitrate on blood pressure, heart rate and exercise capacity in patients with coronary artery disease.
    Glancy DL; Richter MA; Ellis EV; Johnson W
    Am J Med; 1977 Jan; 62(1):39-46. PubMed ID: 319662
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical and circulatory effects of oral isosorbide dinitrate in patients with angina during exercise.
    Lauwers PL; Tackels R
    Acta Cardiol; 1975; 30(4):293-312. PubMed ID: 1084659
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vasodilator therapy for chronic left ventricular failure.
    Kovick RB; Tillisch JH; Berens SC; Bramowitz AD; Shine KI
    Circulation; 1976 Feb; 53(2):322-8. PubMed ID: 812614
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A new oral slow release form of isosorbide dinitrate. Effect on the hemodynamics and exercise capacity of patients with angina.
    Di Bianco R; Ronan JA; Donohue DJ; Lindgren KM
    Chest; 1983 Dec; 84(6):707-13. PubMed ID: 6641305
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Haemodynamic effects of isosorbide dinitrate in patients with congestive cardiac failure at rest and during submaximal supine exercise.
    Stephens JD; Camm AJ; Spurrell RA
    Arch Mal Coeur Vaiss; 1978 Mar; 71(3):241-50. PubMed ID: 416797
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative hemodynamic effects of placebo and oral isosorbide dinitrate in patients with significant coronary artery disease.
    Kasparian H; Wiener L; Duca PR; Gottlieb RS; Brest AN
    Am Heart J; 1975 Jul; 90(1):68-74. PubMed ID: 1094819
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Long-term treatment of chronic congestive heart failure with oral isosorbide dinitrate and phenotoline (author's transl)].
    Lemke R; Lippok R; Kaltenbach M; Bussmann WD
    Z Kardiol; 1979 Feb; 68(2):82-8. PubMed ID: 106563
    [No Abstract]   [Full Text] [Related]  

  • 40. [Clinical use of slow-release isosorbide-5-mononitrate in cardiac insufficiency].
    Caponnetto S; Canale C; Terrachini V; Masperone MA
    Cardiologia; 1987 Nov; 32(11):1303-9. PubMed ID: 3447704
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.